Conference Day One: Wednesday, 17 March 2010 Conference Day One: Wednesday, 17 March 2010
08.00 Registration and refreshments08.45 Organiser’s welcome remarks: Terrapinn Asia08.50 Chairman’s opening remarks Opening leadership roundtable discussion09.00 Cultivating entrepreneurships in biopharmaceutical industry of Asia and beyondEntrepreneurship, whether being a start-up or within an organization, is a key driver of our economy. Wealth and a high majority of jobs are created by small businesses started by entrepreneurially minded individuals, many of whom go on to create big businesses. Gearing up for a global gravity shift towards Asia, biopharma entrepreneurs are facing a wealth of opportunities. What are the success factors that Asia’s emerging biopharma business leaders employ to capture the growth of the industry? Find out the trade secrets when we take you through the journey of entrepreneurship with the most successful entrepreneurs from Asia
- The promises and challenges of Asia’s biopharmaceutical market in an era of healthcare reform
- Looking into the business opportunities in Asia to drive growth and global expansion for Asian and global players
- Finding the right business model and strategy to achieve success in the Asian and global biopharmaceutical arena
President, Riverbank Capital Securities, United States of America Chairman, Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer, Teva Pharmaceutical , Israel Founder, Chairperson & Managing Director, Avesthagen Limited, India
10.15 Morning Refreshments11.00 Chairman’s opening remarks
CEO, ActoKine Therapeutics, United States
Technologies in identifying and validating targets I - (Sponsored by Perkin Elmer)11.05 Utilize biomarkers in target identification in oncology and viral diseases
CEO, ActoKine Therapeutics, United States
11.35 PerkinElmer Solutions for Drug Discovery: from Target Identification/ Validation to Biologics Development
Sales Development Leader BioDiscovery, PerkinElmer, Canada
12.05 Validation of Novel Drug Targets – Lung Inflammation
MD, Professor, Director, UMR6218, Molecular Immunology, University and CNRS, France
Technologies in identifying and validating targets II14.00 Genomic and Proteomic approaches for cancer biomarker development and target validation
Associate Professor, Dept of Pharmacology and Dept of Surgery, National University Hospital System, Singapore
14.30 Molecular analysis of tumor and adjacent tissues to identify HCC targets
Senior Scientific Director, Molecular Profiling Data Analysis, Molecular Profiling Research Informatics, Merck Research Labs, United States
15.00 Integrating Disease Knowledge & Technology for Target Identification & Validation
Director & Chief Scientist, Acumen Research Laboratories, Singapore
15.30 Afternoon refreshment Technologies in lead discovery and optimization16.00 Advance early leads in pipeline to pre-IND stage using a combination of modern functional genomics, in-silico screening, and animal modeling platforms
Chairman and CEO, Shanghai Genomics, Inc/ GNI Ltd., China
16.30 High through put screening methods to fragment based lead discovery
Principal Investigator, Bioinformatics Institute, A*STAR, Singapore
17.00 Impacting Medicinal Chemistry in the hottest areas in cancer: a perspective from Singaporean Biotech
Head, Chemistry, S*BIO, Singapore
17.30 Chairman Closing Remarks17.40 Close of conference day one |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
